Cryptococcal capsular polysaccharide utilizes an antigen-presenting cell to induce a T-suppressor cell to secrete TsF

Journal of Medical and Veterinary Mycology

Volumn 34, Issue 1, 1996, Pages 19-30

  Blackstock, R ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOXYLOMANNAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HYBRIDOMA; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; SECRETION; SPLEEN CELL; SUPPRESSOR CELL;

ANIMALIA; FILOBASIDIELLA NEOFORMANS;

EID: 0029878899     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219680000041     Document Type: Article

References (50)

1. Morgan MA, Blackstock RA, Bulmer GS, Hall NK. Modification of macrophage phagocytosis in murine cryptococcosis. Infect Immun 1983; 40: 493-500.
2. Blackstock R, McCormack JM, Hall NK. Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologie tolerance. Infect Immun 1987; 55: 233-9.
3. Blackstock R, Zembala M, Asherson GL. Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF). I. Picryl and oxazolone specific TsF, which inhibit transfer of contact sensitivity, also inhibit phagocytosis by a subset of marcophages. Cell Immunol 1991; 136: 435-47.
4. Blackstock R, Zembala M, Asherson GL. Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF). II Monoclonal anti-cryptococcal TsF inhibits both phagocytosis by a subset of macrophages and transfer of contact sensitivity. Cell Immunol 1991; 136: 448-61.
5. Asherson GL. Colizzi V, Zembala M. An overview of T-suppressor cell circuits. Annu Rev Immunol 1986; 4: 37-68.
6. Lukacs NW, Boros DL. Lymphokine regulation of granuloma formation in murine Schistosomiasis mansoni. din Immunol Immunopatlwl 1993; 68: 57-63.
7. Hill JO. CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med 1992; 175: 1685-95.
8. Murphy JW. Cytokine profiles associated with induction of the anti-cryptococcal cell-mediated immune response. Infect Immun 1993: 61: 4750-9.
9. Blackstock R. Hall NK, Hernandez NC. Characterization of a suppressor factor that regulates macrophage phagocytosis in murine cryptococcosis. Infect Immun 1989; 57: 1773-9.
10. Sadegh-Nasseri S, Germain RN. How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol Today 1992; 13:43-6.
11. Robinson BE, Hall NK. Bulmer GS, Blackstock R. Suppression of responses to cryptococcal antigen in murine cryptococcosis. Mycopathologia 1982; 80: 157-63.
12. Blackstock R. Hernandez NC. Inhibition of macrophage phagocytosis in cryptococcosis: phenotypic analysis of the suppressor cell. Cell Immunol 1988: 114: 174-87.
13. Dubois M. Gilles KA. Hamilton JK, Rebers RA. Smith F. Colorimetric method for determination of sugar and related substances. Anal Chem 1956; 28: 350-6.
14. Lowry OH. Rosebrough NJ. Farr AL. Randall RJ. Protein measurement with the folin phenol reagent. J Bio/ Chem 1951; 193: 265-75.
15. Becker S. Interferons as modulators of human monocytemacrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan. J Immunol 1984; 132: 1249-54.
16. Stobo JD, Paul WE. Functional heterogeneity of murine lymphoid cells. 3. Differential responsiveness of T cells to phytohemagglutinin and concanavalin A as a probe for T cell subsets. J Immunol 1973; 110: 362-75.
17. Blackstock R. Hernandez NC. Characterization of the macrophage subset affected and its response to a T suppressor factor (TsFmp) found in cryptococcosis. Infect Immun 1989; 57: 2931-7.
18. Muller S. Adorini L. Appella E. Nagy ZA. Lack of influence of cyclosporin on antigen presentation by lysozyme-specific T cell hybridomas. Transplantation 1988; 46(Suppl. 2): 44S-48S.
19. Steele JK. Kuchroo VK. Kawasaki H. et al. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks. J Immunol 1989; 142: 2213-20.
20. Asherson GL, Dorf ME. Colizzi V, Zembala M. James BM. Equivalence of conventional anti-picryl T suppressor factor in the contact sensitivity system and monoclonal anti-NP TsF3: their final non-specific effect via the T acceptor cell. Immunology 1984: 53: 491-7.
21. Dorf ME, Benacerraf B. Suppressor cells and immunoregulation. Ann Rev Immunol 1984; 2: 127-57.
22. Dieli R. Asherson GL, Romano GC, Salerno A. A nonspecific inhibitor of contact sensitivity elaborated by macrophages. Genetic restriction in its production but not in its action. Cell Immunol 1992; 143: 1-10.
23. Inoue T, Asano Y, Matsuoka S, et al. Distinction of mouse CDS + suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms. J Immunol 1993; 150: 2121-8.
24. Bloom BR, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today 1993; 13: 131-6.
25. Murphy JW, Mosley RL, Cherniak R, et al. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun 1988; 56: 424-31.
26. Flood PM, Benoist C, Mathis D, Murphy DB. Altered I-J phenotype in Ea transgenic mice. Proc Nat Acad Sei USA 1986; 83: 8308-12.
27. Jaureguiberry B, Liao L, Kuchroo V, Dorf ME, Diamond B. Monoclonal anti-idiotypic antibodies to an I-J interacting molecule inhibit suppression in an H-2 restricted way. J Immunol 1988; 140: 3286-9.
28. Oliveira DBG, Mitchison NA. Immune suppression genes. Clin Exp Immunol 1989; 75: 167-77.
29. Kawasaki H, Zupko K, Diamond B, Minami M, Dorf ME. Antibody inhibition of suppressor cell induction. J Immunol 1987; 138: 2063-8.
30. Leyva-Cobian F, Unanue ER. Intracellular interference with antigen presentation. J Immunol 1988; 141: 1445-50.
31. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62:4755-61.
32. Collins M, Kuchroo VK, Whitters MJ, et al. Expression of functional alpha-beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding but not with suppressor cell function. J Immunol 1990; 145: 2809-19.
33. Dorf ME, Kuchroo VK, Collins M. Suppressor T cells: some answers but more questions. Immunol Today 1992; 13: 241-3.
34. Mohaptra S, Chen Y, Takata M, Mohaptra SS, Sehon AH. Analysis of T-cell receptor-a chains of CDS + suppressor T cells induced by tolerogenic conjugates of antigen and monomethoxypolyethylene glycol: involvement of TCR ct-CDR3 domain in immunosuppression. J Immunol 1993; 151: 688-98.
35. O'Hara RM, Byrne MC, Kuchroo VK et al. T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction. J Immunol 1995; 154: 2075-81.
36. Green DR, Bissonnette R, Zheng HG et al. Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer. Proc Nat Acad Sei USA 1991; 88: 8475-9.
37. Chen YH, Takata M, Maiti PK et al. The suppressor factor of T-suppressor cells induced by tolerogenic conjugates of ovalbumin and monomethoxypolyethylene glycol is serologically and physicochemically related to the alpha beta heterodomer of the T cell receptor. J Immunol 1994; 152: 3-11.
38. Fairchild RL, Palmer E, Moorhead JW. Production of DNPspecific/class I MHC-restricted suppressor molecules is linked to the expression of T cell receptor alpha- and beta-chain genes. J Immunol 1993; 150: 67-77.
39. Feldmann M, Kontiainen S. Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. Eur J Immunol 1976; 6: 302-5.
40. Ishizaka K, Adachi T. Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses. J Immunol 1976; 117:40-7.
41. Kawasaki H, Martin CA, Uchida T et al. Functional analysis of cloned macrophage hybridomas. V. Induction of suppressor T cell responses. J Immunol 1986; 137: 2145-51.
42. Kawasaki H, Zupko K, Diamond B, Minami M, Dorf ME. Antibody inhibition of suppressor cell induction. J Immunol 1987; 138: 2063-8.
43. Pfrommer GS, Dickens SM , Wilson MA, Young BJ, Kozel TR. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule. Inf Immun 1993; 61: 4360-6.
44. Levitz SM, Tabuni A, Treseler C. Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun 1993; 61: 4891-3.
45. Cherniak R, Morris LC, Andersen BC, Meyer SA. Facilitated isolation, purification and analysis of glucuronoxylomannan of Cryptoccocus neoformans. Infect Immun 1991; 59: 59-64.
46. Blackstock R, Hall HK. Non-specific immuno-suppression by Cryptococcus neoformans infection. Mycopathologia 1984; 86: 35-43.
47. Schimpff SC, Bennett JE. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J Allergy Clin Immunol 1975; 55: 430-41.
48. Goodman JS, Kaufman L, Koenig MG. Diagnosis of cryptococcal meningitis. New Engl J Med 1971; 285: 434-6.
49. Murphy JW. Clearance of Cryptococcus neoformans from immunologically suppressed mice. Infect Immun 1989; 57: 1946-52.
50. Blackstock R. Inhibition of the suppressor cell response to cryptococcal capsule can protect infected mice from loss of DTH and IL-2 responses to a non-capsular cryptococcal antigen In: Abstracts of the 95th General Meeting of the American Society for Microbiology, Washington, DC, 1995. Abstract F-94, p. 103. Washington, DC: American Society for Microbiology.